Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review

被引：0
作者：
Emil ter Veer
Jessy Joy van Kleef
Mirjam A. G. Sprangers
Nadia Haj Mohammad
Martijn G. H. van Oijen
Hanneke W. M. van Laarhoven
机构：
[1] University of Amsterdam,Department of Medical Oncology, Cancer Center Amsterdam, Academic Medical Center
[2] University of Amsterdam,Department of Medical Psychology, Amsterdam Public Health Research Institute, Academic Medical Center
[3] University Medical Center Utrecht,Department of Medical Oncology
来源：
Gastric Cancer | 2018年 / 21卷
关键词：
Quality of life; Randomized controlled trial; Esophageal cancer; Gastric cancer; Systemic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 195
页数：12
相关论文
共 262 条
  • [1] Haj Mohammad N(2015)Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Cancer Metastasis Rev 34 429-441
  • [2] ter Veer E(1998)Reporting on quality of life in randomised controlled trials: bibliographic study BMJ 317 1191-1194
  • [3] Ngai L(2011)Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers Qual Life Res 20 653-664
  • [4] Mali R(2007)Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making Ann Oncol 18 775-781
  • [5] van Oijen MGH(2013)Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer Qual Life Res 22 1787-1803
  • [6] van Laarhoven HWM(2013)Reporting of patient-reported outcomes in randomized trials. The CONSORT PRO extension JAMA 309 814-1553
  • [7] Sanders C(2010)Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial J Clin Oncol 28 1547-117
  • [8] Egger M(2015)Clinical benefit and health-related quality of life assessment in patients treated with cisplatin/S-1 versus cisplatin/5-FU: secondary end point results from the first-line advanced gastric cancer study (FLAGS) J Gastrointest Cancer 46 109-842
  • [9] Donovan J(2013)The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65 +) Eur J Cancer 49 835-187
  • [10] Tallon D(2014)Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Gastric Cancer 17 181-4328
12345678910